Preferred Name

Raloxifene

ID

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C1518

Accepted_Therapeutic_Use_For

Breast cancer; Cardiovascular Disease prophylaxis; Osteoporosis

ALT_DEFINITION

The active ingredient in a drug used to reduce the risk of invasive breast cancer in postmenopausal women who are at high risk of the disease or who have osteoporosis. It is also used to prevent and treat osteoporosis in postmenopausal women. It is also being studied in the prevention of breast cancer in certain premenopausal women and in the prevention and treatment of other conditions. Raloxifene blocks the effects of the hormone estrogen in the breast and increases the amount of calcium in bone. It is a type of selective estrogen receptor modulator (SERM).

CAS_Registry

84449-90-1

CHEBI_ID

CHEBI:8772

Chemical_Formula

C28H27NO4S

code

C1518

Concept_In_Subset

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C116977

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C157712

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C177537

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C157711

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C63923

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C176424

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C128784

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C116978

Contributing_Source

CTRP

GDC

FDA

DEFINITION

A selective benzothiophene estrogen receptor modulator (SERM). Raloxifene binds to estrogen receptors (ER) as a mixed estrogen agonist/antagonist; it displays both an ER-alpha-selective partial agonist/antagonist effect and a pure ER-beta-selective antagonist effect. This agent functions as an estrogen agonist in some tissues (bones, lipid metabolism) and as an estrogen antagonist in others (endometrium and breasts), with the potential for producing some of estrogen's beneficial effects without producing its adverse effects. (NCI04)

Display_Name

Raloxifene

FDA_UNII_Code

YX9162EO3I

FULL_SYN

RALOXIFENE

LY 139481

raloxifene

Keoxifene

[6-Hydroxy-2-(4-hydroxyphenyl)-benzo[b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]methanone

Raloxifene

Has_Salt_Form

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C1762

Has_Target

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C38361

Is_Value_For_GDC_Property

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C1909

label

Raloxifene

Legacy Concept Name

Raloxifene

Maps_To

Raloxifene

NCI_Drug_Dictionary_ID

43109

PDQ_Closed_Trial_Search_ID

43109

PDQ_Open_Trial_Search_ID

43109

Preferred_Name

Raloxifene

prefixIRI

Thesaurus:C1518

prefLabel

Raloxifene

Semantic_Type

Pharmacologic Substance

Organic Chemical

UMLS_CUI

C0752233

subClassOf

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C1821

Delete Subject Author Type Created
No notes to display
Create New Mapping

Delete Mapping To Ontology Source
http://purl.obolibrary.org/obo/CHEBI_8772 Chemical Entities of Biological Interest Ontology / 生物相关的化学实体本体 LOOM
http://purl.obolibrary.org/obo/CHEBI_8772 The Drug Ontology / 药物本体 LOOM
http://purl.obolibrary.org/obo/CHEBI_8772 Experimental Factor Ontology / 实验性因素本体 LOOM
http://purl.bioontology.org/ontology/LNC/LP171633-3 Logical Observation Identifier Names and Codes / 逻辑观察标识符名称和代码 LOOM
http://purl.bioontology.org/ontology/ATC/G03XC01 Anatomical Therapeutic Chemical Classification / 解剖学治疗学及化学分类系统 LOOM